Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals
- 103 Downloads
Certain microRNA molecules (miRNAs) that target genes involved in beta-cell growth and insulin resistance are found deregulated in patients with type-2 diabetes mellitus (T2D) and correlate with its complications. However, the expression profile of miRNAs that regulate genes bearing T2D-related single-nucleotide polymorphisms has been hardly studied. We recently reported that the mRNA patterns of specific T2D-susceptibility genes are impaired in patients, and associate with disease parameters and risk factors. The aim of this study was to explore the levels of miRNAs that target those genes, in peripheral blood of patients versus controls.
A panel of 14 miRNAs validated to target the CDKN2A, CDK5, IGF2BP2, KCNQ1, and TSPAN8 genes, was developed upon combined search throughout the DIANNA TarBase v7.0, miRTarBase, miRSearch v3.0-Exiqon, miRGator v3.0, and miRTarget Link Human algorithms. Specifically developed poly(A)polyadenylation(PAP)-reverse transcription(RT)-qPCR protocols were applied in peripheral blood RNA samples from patients and controls. Possible correlations with the disease, clinicopathological parameters and/or risk factors were evaluated.
T2D patients expressed decreased levels of let-7b-5p, miR-1-3p, miR-24-3p, miR-34a-5p, miR-98-5p, and miR-133a-3p, compared with controls. Moreover, these levels correlated with certain disease features including insulin and % HbA1c levels in patients, as well as BMI, triglycerides’ levels and family history in controls.
A T2D-specific expression profile of miRNAs that target disease-susceptibility genes is for the first time described. Future studies are needed to elucidate the associated transcription-regulatory mechanisms, perchance involved in T2D pathogenesis, and to evaluate the potential of these molecules as possible biomarkers for this disorder.
Let-7b-5p, miR-1-3p, miR-24-3p, miR-34a-5p, miR-98-5p, and miR-133a-3p, which target certain T2D-susceptibility genes, are decreased in peripheral blood samples of patients compared with controls.
The expression levels of let-7b-5p, miR-1-3p, miR-24-3p, miR-34a-5p, miR-98-5p, and miR-133a-3p correlate with the mRNA levels of their target T2D-susceptibility genes.
The levels of these miRNAs correlate with certain disease parameters, including insulin, % HbA1c levels, BMI, triglycerides’ levels, and family history.
KeywordsMicroRNA (miRNA) Type-2 diabetes mellitus (T2D) T2D-susceptibility genes Peripheral blood PAP-RT-qPCR
This research was co-financed by Greece and the European Union (European Social Fund - ESF) through the Operational Program “Human Resources Development, Education and Lifelong Learning” in the context of the project “Scholarships program for post-graduate studies-2nd study Cycle” (MIS-5003404), implemented by the State Scholarships Foundation (IKY).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.International Diabetes Federation, IDF Diabetes Atlas. 7th edn. (International Diabetes Federation, Brussels, Belgium, 2015)Google Scholar
- 6.M.I. Christodoulou, M. Avgeris, I. Kokkinopoulou, E. Maratou, P. Mitrou, C.K. Kontos et al. Blood-based analysis of type-2 diabetes mellitus susceptibility genes identifies specific transcript variants with deregulated expression and association with disease risk. Sci. Rep. 9, 1512 (2019)CrossRefGoogle Scholar
- 39.Expert Panel on Detection E, Treatment of high blood cholesterol in a: executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001)CrossRefGoogle Scholar